Abound Wealth Management Fulgent Genetics, Inc. Transaction History
Abound Wealth Management
- $300 Billion
- Q1 2025
A detailed history of Abound Wealth Management transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Abound Wealth Management holds 56 shares of FLGT stock, worth $1,037. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56
Previous 64
12.5%
Holding current value
$1,037
Previous $1.18 Million
19.95%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding FLGT
# of Institutions
195Shares Held
16.9MCall Options Held
2.36MPut Options Held
47.9K-
Black Rock Inc. New York, NY3.92MShares$72.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$28.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$25.8 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.05MShares$19.4 Million0.0% of portfolio
-
State Street Corp Boston, MA819KShares$15.2 Million0.0% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $561M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...